OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jan 30, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The OPERATION WIPE OUT trial is a project aimed at increasing the number of people in Chambers County, Alabama, who receive the HPV vaccine. HPV, or human papillomavirus, is linked to cervical cancer, and vaccination is recommended for children and adults ages 9 to 26. Unfortunately, vaccination rates in Alabama are low, and the state has one of the highest rates of cervical cancer in the country. This trial is designed to involve high school students in creating and sharing messages about the importance of getting vaccinated, with support from local organizations. By focusing on a community-driven approach, the goal is to improve vaccination rates and ultimately help eliminate cervical cancer as a public health issue in Alabama by 2033.
To participate in this trial, students must be enrolled in the Health Science Program at the Chambers County School District. There are no other specific exclusions mentioned. Participants can expect to work on developing communication campaigns that will help educate their peers and promote HPV vaccination, while also being involved in school-based vaccination efforts. This initiative is part of a larger plan to make a meaningful impact on public health and could serve as a model for similar efforts in other areas.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • High school students enrolled in the Health Science Program at the Chambers County School District, Alabama
- Exclusion Criteria:
- • -
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lafayette, Alabama, United States
Patients applied
Trial Officials
Isabel Scarinci, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported